The heart in Friedreich's Ataxia: Basic findings and clinical implications

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Friedreich's Ataxia is the most common inherited ataxia in man. It is a mitochondrial disease caused by severely reduced expression of the iron binding protein, frataxin. A large GAA triplet expansion in the human FRDA gene encoding this protein inhibits expression of this gene. It is inherited in an autosomal recessive pattern and typically diagnosed in childhood. The primary symptoms include severe and progressive neuropathy, and a hypertrophic cardiomyopathy that may cause death. The cardiomyopathy is difficult to treat and is frequently associated with arrhythmias, heart failure, and intolerance of cardiovascular stress, such as surgeries. Innovative approaches to therapy, such as histone deacetylase inhibitors, and enzyme replacement with cell penetrant peptide fusion proteins, hold promise for this and other similar mitochondrial disorders. This review will focus on the basic findings of this disease, and the cardiomyopathy associated with its diagnosis.

Original languageEnglish
Pages (from-to)103-109
Number of pages7
JournalProgress in Pediatric Cardiology
Volume31
Issue number2
DOIs
StatePublished - May 2011

Fingerprint

Friedreich Ataxia
Mitochondrial Diseases
Cardiomyopathies
Iron-Binding Proteins
Histone Deacetylase Inhibitors
Hypertrophic Cardiomyopathy
Ataxia
Cardiac Arrhythmias
Cause of Death
Proteins
Heart Failure
Gene Expression
Peptides
Enzymes
Therapeutics
frataxin

Keywords

  • Ataxia
  • Cardiomyopathy
  • Genetic
  • Heart
  • Mitochondria
  • Neuropathy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

The heart in Friedreich's Ataxia : Basic findings and clinical implications. / Payne, R.

In: Progress in Pediatric Cardiology, Vol. 31, No. 2, 05.2011, p. 103-109.

Research output: Contribution to journalArticle

@article{1924fbbfd01c47a1ba395cc6716af869,
title = "The heart in Friedreich's Ataxia: Basic findings and clinical implications",
abstract = "Friedreich's Ataxia is the most common inherited ataxia in man. It is a mitochondrial disease caused by severely reduced expression of the iron binding protein, frataxin. A large GAA triplet expansion in the human FRDA gene encoding this protein inhibits expression of this gene. It is inherited in an autosomal recessive pattern and typically diagnosed in childhood. The primary symptoms include severe and progressive neuropathy, and a hypertrophic cardiomyopathy that may cause death. The cardiomyopathy is difficult to treat and is frequently associated with arrhythmias, heart failure, and intolerance of cardiovascular stress, such as surgeries. Innovative approaches to therapy, such as histone deacetylase inhibitors, and enzyme replacement with cell penetrant peptide fusion proteins, hold promise for this and other similar mitochondrial disorders. This review will focus on the basic findings of this disease, and the cardiomyopathy associated with its diagnosis.",
keywords = "Ataxia, Cardiomyopathy, Genetic, Heart, Mitochondria, Neuropathy",
author = "R. Payne",
year = "2011",
month = "5",
doi = "10.1016/j.ppedcard.2011.02.007",
language = "English",
volume = "31",
pages = "103--109",
journal = "Progress in Pediatric Cardiology",
issn = "1058-9813",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - The heart in Friedreich's Ataxia

T2 - Basic findings and clinical implications

AU - Payne, R.

PY - 2011/5

Y1 - 2011/5

N2 - Friedreich's Ataxia is the most common inherited ataxia in man. It is a mitochondrial disease caused by severely reduced expression of the iron binding protein, frataxin. A large GAA triplet expansion in the human FRDA gene encoding this protein inhibits expression of this gene. It is inherited in an autosomal recessive pattern and typically diagnosed in childhood. The primary symptoms include severe and progressive neuropathy, and a hypertrophic cardiomyopathy that may cause death. The cardiomyopathy is difficult to treat and is frequently associated with arrhythmias, heart failure, and intolerance of cardiovascular stress, such as surgeries. Innovative approaches to therapy, such as histone deacetylase inhibitors, and enzyme replacement with cell penetrant peptide fusion proteins, hold promise for this and other similar mitochondrial disorders. This review will focus on the basic findings of this disease, and the cardiomyopathy associated with its diagnosis.

AB - Friedreich's Ataxia is the most common inherited ataxia in man. It is a mitochondrial disease caused by severely reduced expression of the iron binding protein, frataxin. A large GAA triplet expansion in the human FRDA gene encoding this protein inhibits expression of this gene. It is inherited in an autosomal recessive pattern and typically diagnosed in childhood. The primary symptoms include severe and progressive neuropathy, and a hypertrophic cardiomyopathy that may cause death. The cardiomyopathy is difficult to treat and is frequently associated with arrhythmias, heart failure, and intolerance of cardiovascular stress, such as surgeries. Innovative approaches to therapy, such as histone deacetylase inhibitors, and enzyme replacement with cell penetrant peptide fusion proteins, hold promise for this and other similar mitochondrial disorders. This review will focus on the basic findings of this disease, and the cardiomyopathy associated with its diagnosis.

KW - Ataxia

KW - Cardiomyopathy

KW - Genetic

KW - Heart

KW - Mitochondria

KW - Neuropathy

UR - http://www.scopus.com/inward/record.url?scp=79955468608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955468608&partnerID=8YFLogxK

U2 - 10.1016/j.ppedcard.2011.02.007

DO - 10.1016/j.ppedcard.2011.02.007

M3 - Article

AN - SCOPUS:79955468608

VL - 31

SP - 103

EP - 109

JO - Progress in Pediatric Cardiology

JF - Progress in Pediatric Cardiology

SN - 1058-9813

IS - 2

ER -